Genflow Biosciences Plc (GB:GENF)
LSE:GENF
Holding GB:GENF?
Track your performance easily

Genflow Biosciences Plc (GENF) Financial Statements

4 Followers

Genflow Biosciences Plc Financial Overview

Genflow Biosciences Plc's market cap is currently ―. The company's EPS TTM is p-0.005; its P/E ratio is -3.70; Genflow Biosciences Plc is scheduled to report earnings on April 23, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21
Income Statement-
Total Revenue---
Gross Profit---
EBIT---
EBITDA---
Net Income Common Stockholders---
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 2.95M£ 224.00K£ 3.82M
Total Assets£ 3.02M£ 276.55K£ 3.86M
Total Debt£ 0.00£ 0.00£ 0.00
Net Debt£ -2.95M£ -224.00K£ -3.82M
Total Liabilities£ 149.29K£ 221.43K£ 133.99K
Stockholders Equity£ 2.87M£ 55.12K£ 3.72M
Cash Flow-
Free Cash Flow--£ -252.98K
Operating Cash Flow--£ -252.98K
Investing Cash Flow--£ 199.84K
Financing Cash Flow--£ 334.83K
Currency in GBP

Genflow Biosciences Plc Earnings and Revenue History

Genflow Biosciences Plc Debt to Assets

Genflow Biosciences Plc Cash Flow

Genflow Biosciences Plc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis